SYK
NYSE · Health Care
Stryker Corp
$358.29
-4.13 (-1.14%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 24.85B | 22.42B | 43.29B | 43.49B | 43.47B |
| Net Income | 3.21B | 2.61B | 6.04B | 8.24B | 6.44B |
| EPS | — | — | — | — | — |
| Profit Margin | 12.9% | 12.3% | 13.9% | 18.9% | 14.8% |
| Rev Growth | +10.8% | +10.8% | +5.6% | +22.5% | +13.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 27.31B | 27.31B | 37.67B | 32.34B | 34.71B |
| Total Equity | 41.20B | 41.20B | 63.92B | 61.80B | 69.01B |
| D/E Ratio | 0.66 | 0.66 | 0.59 | 0.52 | 0.50 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 5.19B | 4.45B | 10.38B | 9.81B | 9.91B |
| Free Cash Flow | — | — | 5.65B | 3.51B | 3.84B |